Transforming Health Care Through Evidence and Collaboration
Transforming Health Care Through Evidence and Collaboration
  • alliance-standard-logo-rgb-1200
  • ahcj-logo-2
ShareThis

Prescription Drug Costs: Can Increased Competition Restrain Prices?

June 14, 2018 | 01:00 PM
02:15 PM ET

There is growing momentum among policymakers to address rising prescription drug prices. One approach is to use market forces to bring down costs by increasing competition through generics and biosimilars. During this webinar, panelists discussed opportunities and challenges in the generic and biosimilar market, how past administrations have approached this issue, and the impact on different stakeholders, including consumers.

This webinar is a project of the Alliance for Health Policy and NIHCM Foundation, in collaboration with the Association of Health Care Journalists.

Learn More

Speakers

Sameer Awsare, MD
The Permanente Medical Group
Andrew Barnhill, JD
GlaxoSmithKline
Dora Hughes, MD
Sidley Austin LLp
Robert Langreth
Bloomberg News